Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant: PHSI for Cancer Control - LOI

McMaster University

$19,873.00

Optimizing Cancer Survivorship Care through Risk Stratification

FY 2016-17

Summary
This study will look at ways to better identify how cancer survivors should be followed after they complete treatment. In this proposal the study team, that includes family doctors, oncologists, nurses, cancer survivors and health system administrators, will develop a way to identify whether a cancer survivor needs to stay in contact with the oncology team or can transition to their family doctor, when appropriate. The team will develop and test a method to determine if a survivor is low, intermediate or high risk for the cancer returning or complications of treatment. This will help improve the effectiveness of cancer care being provided by family doctors and oncology teams.
Program
Operating Grant: PHSI for Cancer Control - LOI
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
361117
Name
Sussman Jonathan
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Health systems / services
Prcname2
PHSI for Cancer Control (LOI)
Projecttitle
Optimizing Cancer Survivorship Care through Risk Stratification
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$19,873
Cihrequipment2
$0
Programname2
Operating Grant: PHSI for Cancer Control - LOI
Keyworddelim
Cancer Survivorship; Health Services; Models Of Care; Risk
Abstract
This study will look at ways to better identify how cancer survivors should be followed after they complete treatment. In this proposal the study team, that includes family doctors, oncologists, nurses, cancer survivors and health system administrators, will develop a way to identify whether a cancer survivor needs to stay in contact with the oncology team or can transition to their family doctor, when appropriate. The team will develop and test a method to determine if a survivor is low, intermediate or high risk for the cancer returning or complications of treatment. This will help improve the effectiveness of cancer care being provided by family doctors and oncology teams.
Competitiondate
201610
Approvedterm2
1 yr 0 mth
Pinamesdelim
Sussman, Jonathan; Mcleod, Robin S
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $19,873~ $0~